✨ Free AI Report
4D Molecular Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview 4D Molecular Therapeutics, Inc.
Research Preview

4D Molecular Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evol...

Analyst-debate audio for 4D Molecular Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for 4D Molecular Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
4D Molecular Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Late-stage gene therapy company with promising lead ophthalmology program advancing toward commercial potential, supported by...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest 4D Molecular Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

4D Molecular Therapeutics, Inc. Overview

Pro stress-test →

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evolution that combines directed evolution with synthetic AAV capsid sequences to create targeted genetic medicines.

Strategic Profile

Pro stress-test →

Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V.

Competitive Landscape

Pro stress-test →

4D Molecular Therapeutics competes in the gene therapy sector against other AAV-based platforms and modalities. Key competitive areas include ophthalmology (competing with companies like Astellas and established biopharmaceutical players) and specialty rare diseases. The company's differentiation lies in its Therapeutic Vector Evolution platform enabling tailored AAV vector development.

Industry Context

4D Molecular Therapeutics, Inc. operates in Biotechnology - Gene Therapy.

Key facts

Founded: 2013 · Headquarters: Emeryville, California · Employees: 227 · Revenue: $120K · Market cap: $505M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on 4D Molecular Therapeutics, Inc..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when 4D Molecular Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Adeno-associated virus (AAV) gene therapiesStrategic partner in ophthalmology and gene therapy development→CRISPR and gene editing therapiesAlternative genetic medicine approaches→Traditional anti-VEGF therapiesStandard of care for wet AMD and DME→

Compare 4D Molecular Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

4D Molecular Therapeutics, Inc. operates in Biotechnology - Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Therapy research →
NEW · MCP server

Ask your AI assistant about 4D Molecular Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare 4D Molecular Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did 4D Molecular Therapeutics, Inc. do this quarter?”
“Is 4D Molecular Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does 4D Molecular Therapeutics, Inc. do?+
4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evol...
What is 4D Molecular Therapeutics, Inc.'s Cyborg Score?+
4D Molecular Therapeutics, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are 4D Molecular Therapeutics, Inc.'s main competitors?+
Named competitors include Adeno-associated virus (AAV) gene therapies, CRISPR and gene editing therapies, Traditional anti-VEGF therapies. The full competitive landscape is in the AskCyborg report.
How can I get the full 4D Molecular Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the 4D Molecular Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track 4D Molecular Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology - Gene Therapy research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Neurogene Inc.7MeiraGTx Holdings plc7REGENXBIO Inc.6Takara Bio Inc.6Voyager Therapeutics, Inc.5Rocket Pharmaceuticals, Inc.